https://pharmoniq.com/news/cemdisiran-nimble-trial-results-neurological-disease PharmoniQ en 2026-04-27T14:10:49.777Z Cemdisiran Hits Key Endpoints in NIMBLE Trial for Neurological Disease cemdisiran, clinical-trials, neurology, RNAi-therapeutics, patient-compliance https://pharmoniq.com/news/cycle-pharmaceuticals-halts-govorestat-cmt-sord-trials PharmoniQ en 2026-04-26T14:10:49.085Z Cycle Pharma Terminates Govorestat Development for Rare CMT Disease clinical trials, rare disease, CMT, govorestat, drug development https://pharmoniq.com/news/grace-therapeutics-bleeding-stroke-drug-fda-rejection-2024 PharmoniQ en 2026-04-26T08:47:01.879Z Grace Therapeutics' Stroke Drug Rejected by FDA, Shares Fall 45% FDA approval, stroke treatment, biotechnology, clinical trials, regulatory affairs